TCWM
KRYS icon

Total Clarity Wealth Management’s Krystal Biotech KRYS Stock Holding History

Total Clarity Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
+890
New +$266K 0.06% 284
2022
Q1 		– Sell
-50
Closed -$3K – 594
2021
Q4 		$3K Buy
+50
New +$2.91K ﹤0.01% 879

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Total Clarity Wealth Management's KRYS Position: Q2 2026 in Review

Total Clarity Wealth Management opened a new position in Krystal Biotech (KRYS) in Q2 2026: 890 shares worth $331K. The stake represents 0.06% of the portfolio and ranks #284 among its holdings. This is a return to the name: Total Clarity Wealth Management previously reported a position in KRYS as recently as Q4 2021.

Total Clarity Wealth Management first reported a position in KRYS in Q4 2021 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Total Clarity Wealth Management held 890 shares of Krystal Biotech worth $331K as of Q2 2026.
  • Krystal Biotech was a new Total Clarity Wealth Management position in Q2 2026.
  • Krystal Biotech made up 0.06% of Total Clarity Wealth Management's portfolio in Q2 2026, its #284 holding.
  • Total Clarity Wealth Management first reported a position in Krystal Biotech in Q4 2021 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.